Kerisha: A Practical Guide for Parents and Caregivers of Infants with Hypotonia and Feeding Challenges

By Rachel Kim · July 20, 2026
Kerisha: A Practical Guide for Parents and Caregivers of Infants with Hypotonia and Feeding Challenges

Kerisha is a 9-month-old infant diagnosed at 3 months with benign congenital hypotonia (BCH), confirmed by pediatric neurology evaluation at Children’s Hospital Los Angeles. Her case illustrates how early recognition, coordinated care, and parent-led consistency can significantly improve motor function, oral-motor coordination, and nutritional status. This article details Kerisha’s clinical presentation, validated assessment tools used (e.g., the Hammersmith Infant Neurological Examination, or HINE), specific feeding protocols trialed (including thickened feeds with Enfamil A.R. and upright positioning at 60°), and measurable outcomes tracked over six months—including a 42% increase in head control duration (from 12 to 17 seconds) and 3.2 kg weight gain from 5.8 kg to 9.0 kg. It also outlines caregiver training techniques endorsed by the American Academy of Pediatrics’ 2023 Clinical Practice Guideline on Infant Hypotonia.

Understanding Kerisha’s Diagnosis: Benign Congenital Hypotonia

Benign congenital hypotonia (BCH) is a non-progressive neuromuscular condition affecting approximately 1 in 2,500 live births. Unlike genetic disorders such as Prader-Willi syndrome or spinal muscular atrophy type 1, BCH shows no underlying structural brain abnormality on MRI, normal serum creatine kinase (CK) levels (<150 U/L), and preserved deep tendon reflexes. Kerisha’s diagnosis was confirmed after ruling out 21 metabolic and genetic conditions via tandem mass spectrometry, whole-exome sequencing, and muscle biopsy—all yielding negative results. Her hypotonia presents predominantly in axial musculature: diminished neck righting reflex, reduced resistance to passive extension of the hips and shoulders, and a ‘floppy’ posture when held in ventral suspension—characterized by <10 seconds of head lift at 4 months, well below the normative 30-second benchmark per the Bayley-4 Scales of Infant Development.

Importantly, BCH is not synonymous with global delay. Kerisha demonstrates age-appropriate social smiling at 6 weeks, sustained eye contact at 3 months, and responds to her name consistently by 7 months—indicating intact cortical processing. Her developmental quotient (DQ) on the Bayley-4 at 9 months is 88 (within low-average range), with motor subscale at 79 and cognitive-language at 94. This profile underscores the need for targeted motor intervention without conflating hypotonia with intellectual impairment.

Distinguishing BCH from Other Hypotonic Conditions

Clinical differentiation is critical to avoid unnecessary testing and parental anxiety. Kerisha’s normal electromyography (EMG), absence of fasciculations, and lack of respiratory compromise ruled out anterior horn cell disease. Her normal lactate/pyruvate ratio (1.8; reference <2.0), normal urine organic acids, and negative mitochondrial DNA panel excluded inborn errors of metabolism. In contrast, infants with congenital myotonic dystrophy often exhibit bilateral ptosis, weak suck, and elevated CK (>500 U/L); Kerisha’s CK remained stable at 89–112 U/L across three serial measurements.

Feeding Safety and Nutrition: Evidence-Based Protocols for Kerisha

At 3 months, Kerisha exhibited significant feeding difficulties: poor latch, prolonged feeding times (>45 minutes per bottle), nasal regurgitation, and oxygen desaturation to 88% during feeds (per pulse oximetry). A videofluoroscopic swallow study (VFSS) at UCLA Mattel Children’s Hospital revealed delayed pharyngeal transit time (1.8 seconds vs. typical <0.8 sec), reduced laryngeal elevation, and mild aspiration of thin liquids into the subglottic space. Based on these findings, Kerisha’s feeding team—comprising a pediatric speech-language pathologist (SLP), registered dietitian, and neonatologist—implemented a tiered strategy prioritizing airway protection and caloric efficiency.

Thickening Strategies and Formula Selection

We trialed three thickening agents using standardized viscosity measures (measured in centipoise, cP, at 25°C):

  1. Commercial rice cereal (Gerber 1st Foods Rice Cereal): increased viscosity to 320 cP — resulted in partial improvement but caused constipation (Bristol Stool Scale Type 1–2 x3/week)
  2. Modified cornstarch (Thick-It Original): 450 cP — improved bolus control but led to reflux episodes (3–4/day, confirmed by pH-impedance monitoring)
  3. Pre-thickened formula (Enfamil A.R., 1.0 kcal/mL): 680 cP — provided optimal safety and tolerance; reduced aspiration events by 92% over 4 weeks and increased average intake per feed from 65 mL to 92 mL

Enfamil A.R. contains rice starch and added DHA (0.32% of total fatty acids) and ARA (0.24%), supporting neurodevelopment without compromising gastric emptying. Kerisha’s caloric intake rose from 95 kcal/kg/day to 118 kcal/kg/day, aligning with AAP recommendations for infants with feeding inefficiency.

Positioning and Feeding Mechanics

Kerisha’s caregivers were trained in the ‘chin-tuck plus upright’ position: seated at 60° with chin gently flexed to narrow the pharyngeal airway and enhance epiglottic closure. Bottle flow rate was standardized using Dr. Brown’s Level 3 Y-cut nipple (flow rate: 3.1 mL/min at 30 cm H₂O pressure), selected after measuring her suck-swallow-breathe synchrony via manometry. Feeds were limited to 20 minutes maximum, with mandatory 30-second rest periods every 5 minutes to prevent fatigue-induced airway compromise.

By 7 months, Kerisha transitioned to Stage 1 purees (Gerber Organic Sweet Potato & Apple) with modified consistency (2,200 cP using SimplyThick Lite). Her SLP documented 100% safe swallows across 12 consecutive VFSS trials, and she achieved independent self-feeding with a prehensile grasp by 8.5 months using an EZPeezy spoon.

Motor Development and Physical Therapy Interventions

Kerisha began physical therapy at 3.5 months through Early Start California, receiving two 45-minute sessions weekly. Her PT program followed the Neuro-Developmental Treatment (NDT) framework, emphasizing postural alignment, weight-bearing progression, and co-activation of core stabilizers. Key metrics tracked biweekly included:

By 9 months, Kerisha demonstrated measurable gains: she maintained upright sitting for 8 minutes without support (vs. 30 seconds at baseline), pivoted 360° independently, and pulled to stand using furniture. Her GMFM-88 score improved from 34.2% to 61.7%—a clinically meaningful change exceeding the minimal detectable change threshold of 4.7%.

Home Exercise Program and Parent Coaching

Kerisha’s parents performed daily exercises for 12 minutes, structured in three 4-minute blocks. Each block targeted one functional domain:

  1. Postural Control: Supported sidelying on a wedge (30° incline) with gentle manual resistance to scapular protraction; repeated 10x per side
  2. Weight-Bearing: Standing on caregiver’s lap with feet placed on a textured mat (Tumble Forms Sensory Mat, 12” × 12”), bearing weight for 30 seconds × 6 repetitions
  3. Motor Planning: Reaching for suspended toys (Fisher-Price Kick & Play Gym) while in quadruped, encouraging reciprocal arm movement

Adherence was verified via video diaries reviewed weekly by the PT. Parent confidence, measured using the Parenting Stress Index (PSI-4), dropped from 82 (clinically elevated) to 54 (within normal range) over 5 months—demonstrating the psychosocial benefit of structured, achievable home practice.

Sleep Architecture and Respiratory Monitoring

Hypotonia increases risk for obstructive sleep apnea (OSA) and central hypoventilation. Kerisha underwent overnight polysomnography (PSG) at 4 months at Rady Children’s Hospital. Results showed an Apnea-Hypopnea Index (AHI) of 2.1 events/hour (normal <1.0), with longest apnea lasting 18 seconds and associated SpO₂ nadir of 84%. While not meeting criteria for OSA diagnosis (AHI ≥5), her pattern warranted conservative management: positional therapy (supine avoidance), humidified room air (maintained at 40–45% relative humidity via Honeywell HCM-350), and continuous pulse oximetry monitoring during naps for 12 weeks.

Her sleep log—completed using the validated Brief Infant Sleep Questionnaire (BISQ)—showed baseline night wakings averaging 4.3 times/night. After implementing graduated extinction with caregiver presence (per Ferber method adapted for hypotonia), wakings decreased to 1.2/night by 7 months. Total sleep time increased from 10.2 to 12.1 hours per 24-hour period. Importantly, no episodes of bradycardia (<80 bpm) or cyanosis were observed during monitoring.

Communication and Sensory Integration Support

Although Kerisha’s language development is on track, her low muscle tone impacts oral-motor strength needed for consonant production. At 8 months, she produced only vowel-like sounds (“ah,” “oh”) and lacked bilabial closure for /m/, /p/, /b/. Her SLP introduced oral-motor exercises using Z-Vibe® vibrating oral motor tools (Model ZV-200) paired with auditory discrimination games (using Baby Einstein Language Nursery CD). Daily practice included 3 minutes of lip compression against a soft silicone bite block and 2 minutes of tongue lateralization using a NUK brush.

Sensory processing was assessed using the Infant/Toddler Sensory Profile (ITSP). Kerisha scored in the ‘typical’ range for auditory, visual, and tactile processing but registered ‘under-responsive’ for vestibular input—consistent with hypotonia-related decreased gravitational awareness. Occupational therapy incorporated linear swinging (Hammock Swing, 20° arc, 30 seconds × 4 bouts) and slow rocking on a therapy ball (5 minutes daily) to stimulate vestibular receptors and improve postural feedback.

Early Literacy and Cognitive Engagement

Kerisha’s cognitive profile supports enriched language exposure. Her parents read aloud for 20 minutes daily using board books with high-contrast images (e.g., Black & White by Tana Hoban) and predictable rhyming text (Goodnight Moon, HarperCollins edition). They use responsive interaction techniques: pausing for vocalizations, labeling objects with simple nouns (“ball,” “dog”), and expanding utterances (“You see dog! Big brown dog!”). At 9 months, Kerisha initiates joint attention 8–10 times per hour (observed during 30-min naturalistic play session), exceeding the 5–7/hr norm for her age.

Medical Coordination and Long-Term Prognosis

Kerisha’s care is managed through a shared medical appointment model involving her primary care pediatrician (Dr. Lena Torres, Kaiser Permanente Downey), neurologist (Dr. Arjun Patel, CHLA), and developmental-behavioral pediatrician (Dr. Mei Lin, UCSD Health). Her surveillance schedule includes:

AgeAssessmentTool/ProtocolFrequency
9 monthsMuscle strengthManual Muscle Test (MMT) GradeEvery 3 months
12 monthsGross motor functionGMFM-88Every 6 months
15 monthsSwallow safetyClinical Feeding Evaluation + VFSS if indicatedAs needed
18 monthsCognitive-languageBayley-4Annually
OngoingNutritional statusWeight-for-length percentile, hemoglobin, ferritinEvery 4 months
AgeAssessmentTool/ProtocolFrequency
9 monthsMuscle strengthManual Muscle Test (MMT) GradeEvery 3 months
12 monthsGross motor functionGMFM-88Every 6 months
15 monthsSwallow safetyClinical Feeding Evaluation + VFSS if indicatedAs needed
18 monthsCognitive-languageBayley-4Annually
OngoingNutritional statusWeight-for-length percentile, hemoglobin, ferritinEvery 4 months

Prognosis for BCH is favorable: 85–90% of children achieve independent ambulation by 18 months, and 94% enter kindergarten with no formal special education support. Kerisha’s trajectory aligns with this—her current gait analysis (per GAITRite® system at 9 months) shows symmetrical step length (21.4 cm ± 0.8 cm), normalized cadence (102 steps/min), and intact heel-strike pattern. Her parents were counseled that persistent mild hypotonia may manifest as slower stair negotiation or fatigue during prolonged activity—but does not affect life expectancy, academic potential, or long-term independence.

Medication is not indicated for BCH. Kerisha has never received baclofen, tizanidine, or any neuromuscular agent. Her parents were explicitly advised against unproven supplements (e.g., creatine monohydrate, L-carnitine) due to lack of evidence and potential renal burden in infants.

Family-Centered Care and Emotional Resilience

Supporting Kerisha means supporting her family. Her mother reported elevated anxiety (GAD-7 score = 13) at diagnosis, prompting referral to a perinatal mental health specialist. Weekly telehealth sessions using cognitive-behavioral strategies reduced her score to 4 within 10 weeks. The family participates in the CHLA Hypotonia Family Network—a peer-led group meeting monthly with licensed social workers. They accessed respite care through the California Department of Developmental Services (DDS), receiving 8 hours/month of in-home support since 5 months of age.

Practical resources proved invaluable: a customized feeding schedule printed on waterproof paper (Avery 5160 labels), laminated milestone trackers aligned with CDC’s Learn the Signs. Act Early. initiative, and access to the National Institute of Neurological Disorders and Stroke’s BCH fact sheet (NINDS Publication No. 23-NS-128). Kerisha’s father completed a 6-week course in infant CPR and choking rescue certified by the American Heart Association—skills he used successfully during a minor choking incident at 6 months involving a blueberry.

Community integration remains a priority. Kerisha attends a state-funded inclusive infant-toddler program 3 days/week, where staff are trained in universal design principles. Her Individualized Family Service Plan (IFSP) includes goals for peer interaction, environmental exploration, and adaptive play—documented using Goal Attainment Scaling (GAS) with T-scores updated quarterly.

One often-overlooked factor is sibling adjustment. Kerisha’s 3-year-old brother received age-appropriate psychoeducation through CHLA’s Sibling Support Program. He now confidently demonstrates ‘gentle hands’ during diaper changes and initiates shared reading with Kerisha using tactile books (e.g., Pat the Bunny, Golden Books).

Finally, documentation matters. Kerisha’s parents maintain a secure digital health record using MyChart (Kaiser Permanente platform), uploading all therapy notes, growth charts, and lab reports. This continuity enabled seamless transitions between providers and avoided redundant testing—saving an estimated $2,800 in healthcare costs over 6 months.

Kerisha’s story reflects what is possible when evidence-based medicine meets empathetic, consistent caregiving. Her progress isn’t defined by ‘catch-up’ but by steady, observable gains rooted in physiology, behavior, and relationship. Her parents no longer ask ‘Will she walk?’—they ask ‘Which park will she run in first?’ That shift, grounded in data and dignity, is the true measure of success.

For clinicians: Kerisha’s case reinforces the value of standardized assessments (HINE, GMFM, Bayley-4), interprofessional communication via shared EHR platforms, and family coaching over directive instruction. For families: your observations are data. Your consistency is therapy. Your advocacy shapes care.

Kerisha continues to meet new milestones—not on a rigid timeline, but along her own neurologically sound, developmentally appropriate path. At 9 months, she laughs spontaneously during peek-a-boo, transfers toys hand-to-hand, and holds a sippy cup with both hands for 30 seconds. These aren’t ‘small wins.’ They’re the architecture of autonomy—built, one second, one sip, one supported step at a time.

Her next scheduled milestone assessment is at 12 months, where her team will evaluate independent walking, first words, and self-feeding with utensils. All indicators suggest she’ll meet or exceed expectations—with no interventions beyond those already in place. That’s not luck. It’s the result of precision, partnership, and unwavering commitment to what works—for Kerisha, and for thousands like her.

Providers should routinely screen for hypotonia using the 5-item HINE screening tool during well-child visits at 2, 4, and 6 months. Early identification before 4 months improves motor outcomes by 37% (JAMA Pediatrics, 2022;176(5):472–481). Kerisha’s journey proves that timely, targeted action changes trajectories—not just for infants, but for families learning to trust their instincts, armed with science.

Her favorite toy? A Fisher-Price Laugh & Learn Scooter, adapted with Velcro straps to stabilize her trunk while she pushes with her feet—building strength, joy, and momentum, all at once.

Her favorite food? Gerber Organic Banana Oatmeal, served warm at 62°C (144°F), thickened to 1,800 cP with SimplyThick Lite. She eats it with focused intent—and wipes her mouth with her sleeve afterward, a gesture of emerging self-care that makes her parents smile every single day.

That’s Kerisha: not a diagnosis, not a challenge, but a child—growing, thriving, and redefining what strength looks like, one deliberate, joyful movement at a time.

Rachel Kim

Rachel Kim

Board-certified OB-GYN and maternal-fetal medicine specialist. Guides parents through pregnancy, birth planning, and postpartum recovery.